Clinical Trials

NCT05101213 | TERMINATED | PHASE1
12 participants

Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2023-01-06
Completion:
2026-08-03
Conditions
  • Adenovirus Infection
  • BK Virus Infection
  • Cytomegaloviral Infection
  • Hematopoietic and Lymphoid Cell Neoplasm
  • JC Virus Infection
  • Malignant Solid Neoplasm
  • Symptomatic COVID-19 Infection Laboratory-Confirmed
Interventions
  • BIOLOGICAL
No Results Yet
NCT05091957 | RECRUITING | NA
80 participants

Connecting Families

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2022-05-17
Completion:
2027-04-30
Conditions
  • Poverty
  • Primary Care
  • Intervention
Interventions
  • OTHER
No Results Yet
NCT05050214 | COMPLETED | PHASE2
20 participants

Obinutuzumab in Primary MN

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2022-02-18
Completion:
2026-03-12
Conditions
  • Membranous Nephropathy
Interventions
  • DRUG
No Results Yet
NCT04976712 | RECRUITING
256 participants

Core Temperature in Patients With OHCA

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-11
Start Date:
2021-07-01
Completion:
2027-09-30
Conditions
  • Out-Of-Hospital Cardiac Arrest
  • Accidental Hypothermia
  • Temperature Change, Body
No Results Yet
NCT04887805 | ACTIVE_NOT_RECRUITING | PHASE2
28 participants

Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2021-07-21
Completion:
2026-03-22
Conditions
  • Advanced Pancreatic Ductal Adenocarcinoma
  • Stage II Pancreatic Cancer AJCC v8
  • Stage IIA Pancreatic Cancer AJCC v8
  • Stage IIB Pancreatic Cancer AJCC v8
  • Stage III Pancreatic Cancer AJCC v8
  • Stage IV Pancreatic Cancer AJCC v8
  • Unresectable Pancreatic Ductal Adenocarcinoma
Interventions
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT04858334 | RECRUITING | PHASE2
152 participants

APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2021-06-22
Completion:
2027-10-31
Conditions
  • Pancreatic Acinar Cell Carcinoma
  • Pancreatic Adenosquamous Carcinoma
  • Pancreatic Squamous Cell Carcinoma
  • Resectable Pancreatic Acinar Cell Carcinoma
  • Resectable Pancreatic Adenocarcinoma
  • Resectable Pancreatic Adenosquamous Carcinoma
  • Resectable Pancreatic Carcinoma
Interventions
  • PROCEDURE
  • DRUG
No Results Yet
NCT04837716 | ACTIVE_NOT_RECRUITING | PHASE1
12 participants

Ensartinib, Carboplatin, Pemetrexed and Bevacizumab for the Treatment of Stage IIIC or IV or Recurrent ALK-Positive Non-small Cell Lung Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-11
Start Date:
2021-03-18
Completion:
2027-09-23
Conditions
  • Metastatic Lung Non-Small Cell Carcinoma
  • Recurrent Lung Non-Small Cell Carcinoma
  • Stage IIIC Lung Cancer AJCC v8
  • Stage IV Lung Cancer AJCC v8
  • Stage IVA Lung Cancer AJCC v8
  • Stage IVB Lung Cancer AJCC v8
Interventions
  • DRUG
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page